Cargando…
Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma
BACKGROUND: This study was performed to determine the ability to escalate drug doses in a 15‐week CHOP protocol in dogs with multicentric lymphoma. HYPOTHESIS: We hypothesized that at least 50% of dogs could successfully be escalated in at least 1 drug. Secondary aims were to establish objective res...
Autores principales: | Siewert, Jacob M., Gustafson, Daniel L., Weishaar, Kristen M., Galloway, Annie M., Thamm, Douglas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658528/ https://www.ncbi.nlm.nih.gov/pubmed/37787577 http://dx.doi.org/10.1111/jvim.16875 |
Ejemplares similares
-
Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs
por: Cawley, Jacob R., et al.
Publicado: (2020) -
Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021) -
Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma
por: Thamm, D.H., et al.
Publicado: (2017) -
Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy
por: Faulhaber, Erica A., et al.
Publicado: (2021) -
Prospective evaluation of the lymph node proteome in dogs with multicentric lymphoma supplemented with sulforaphane
por: Parachini‐Winter, Cyril, et al.
Publicado: (2020)